Tumor necrosis factor-alpha inhibitor use for treatment of refractory cardiac sarcoidosis in a patient with left ventricular assist device: Adalimumab use in refractory sarcoidosis in a patient with left ventricular assist device.
Citation: Journal of Heart & Lung Transplantation. 39(12):1504-1505, 2020 12.PMID: 32830024Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): LetterSubject headings: *Adalimumab/tu [Therapeutic Use] | *Cardiomyopathies/th [Therapy] | *Heart Failure/th [Therapy] | *Heart-Assist Devices | *Sarcoidosis/th [Therapy] | *Tumor Necrosis Factor-alpha/ai [Antagonists & Inhibitors] | Adult | Anti-Inflammatory Agents/tu [Therapeutic Use] | Cardiomyopathies/co [Complications] | Cardiomyopathies/di [Diagnosis] | Female | Heart Failure/di [Diagnosis] | Heart Failure/et [Etiology] | Humans | Positron-Emission Tomography | Sarcoidosis/co [Complications] | Sarcoidosis/di [Diagnosis] | Treatment OutcomeYear: 2020ISSN:- 1053-2498
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 32830024 | Available | 32830024 |
English